Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies ...
Synthesis and Stability of Actinium-225 Endohedral Fullerenes, 225Ac ...
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle ...
225Ac Prostate-Specific Membrane Antigen Posttherapy α Imagi ...
Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted ...
The 225Ac decay chain. Photons with a branching ratio >3% relative to ...
Treatment of Prostate Cancer With CD46 Targeted 225ac Alpha Particle ...
Production of 225Ac for medical application from 232Th-metallic targets ...
177Lu and 225Ac dose escalation using a novel class of PSMA ...
Targeted Alpha Therapy: All We Need to Know about 225Ac’s Physical ...
Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According ...
[225Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer ...
225Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine ...
Frontiers | Alpha-peptide receptor radionuclide therapy using actinium ...
ASCO 2025: PSMA-Targeted Actinium-225 Therapy in Metastatic Castration ...
A Review of Theranostics: Perspectives on Emerging Approaches and ...
Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High ...
ASCO 2024: A Phase 1 Study of JNJ-69086420 (JNJ-6420), an Actinium-225 ...
Navigating the safety profile of Actinium-225 targeted alpha therapy: a ...
Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA ...
开发针对 PSMA 的新型 111In/225Ac 标记药物，用于高效癌症放射治疗,Journal of Medicinal ...
ACTINIUM (225AC) LINTUZUMAB SATETRAXETAN • Clasificación Arancelaria
Treatment of Patients with Acute Myeloid Leukemia with the Targeted ...
Long-Term Safety and Survival Outcomes of [225Ac]Ac-PSMA (Prostate ...
225Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide ...
SNMMI 2025: How About Actinium-225?
Actinium-225 (225Ac) is an alpha radiator that has | Chegg.com
Abstract ND09: Actinium-225 -PSMA-Trillium (BAY 3563254): Preclinical ...
What is the efficacy of Alpha particle radio pharmaceuticals, such as ...
Actinium-225 PSMA Therapy: Breakthrough Treatment for Advanced Prostate ...
Brookhaven now capable of processing Ac-225 on site -- ANS / Nuclear ...
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac ...
H2BZmacropa-NCS: A Bifunctional Chelator for Actinium-225 Targeted ...
Actinium (225Ac) vipivotidum tetraxetanum(Actinium (225Ac) vipivotidum ...
Clinical Experience with [225Ac]Ac-PSMA Treatment in Patients with ...
一种生产医用同位素225Ac的方法和装置与流程
FDA Clears 225Ac-SSO110 for Phase 1/2 SCLC and Merkel Cell Carcinoma Trial
Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model ...
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa ...
FDA Clears Full-Life Tech's 225Ac-FL-020 for Treating Metastatic ...
(PDF) An Overview of Targeted Alpha Therapy with 225 Actinium and 213 ...
Design of 225Ac-PSMA for targeted alpha therapy in prostate cancer - PMC
225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell ...
Actinium-225 targeted alpha particle therapy for prostate cancer - PMC
国内首个225Ac放射性药物的注册临床试验申请获受理 - 中国核技术网
225Ac-Psma-R2 – Application in Therapy and Current Clinical Research
(PDF) Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy ...
Structural formula of [ 225 Ac]Ac-PSMA-I&T, with DOTAGA as a chelator ...
Actinium-225 targeted alpha particle therapy for prostate cancer
Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a ...
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer ...
FAP-Targeted Radiopeptide Therapy using 177Lu-, 225Ac- and 90Y-labeled ...
Figure 4 from Preclinical Evaluation of 225Ac-Labeled Single-Domain ...
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the ...
Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in ...
Effectiveness of 225Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR ...
Figure 1 from 225Ac-Labeled Antibody for Fibroblast Activation Protein ...
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T ...
225Ac-Psma-R2 – Aplicación en terapia e investigaciones clínicas actuales
Hitachi, Tohoku University and Kyoto University Become World's First to ...
ASCO 2025: Radioligand Therapy Remix: Finding the Right Patient for the ...
Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer ...
Development of an actinium-225 radioimmunoconjugate for targeted alpha ...
Signaling Network Response to α-Particle–Targeted Therapy with the ...
(PDF) In vitro dose effect relationships of actinium-225- and lutetium ...
Exploring the Therapeutic Potential of 225Ac-NM600 for Aggressive ...
(PDF) Targeted α-Therapy Using 225 Ac Radiolabeled Single-Domain ...
ASCO 2023: Phase I Dose-Escalation Results of PSMA Targeted ...
Advances in 177Lu-PSMA and 225Ac-PSMA Radionuclide Therapy for ...
Development of a 225Ac-Labeled PSMA Agent with 18F Labeling Capability ...
